Cargando…
COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study
OBJECTIVE: Individuals with schizophrenia may be at an increased risk for COVID-19 morbidity due to the disease characteristics. In this study, we aimed to explore the odds of significant COVID-19 morbidity and mortality among schizophrenia patients while controlling for potential sociodemographic a...
Autores principales: | Tzur Bitan, Dana, Krieger, Israel, Kridin, Khalaf, Komantscher, Doron, Scheinman, Yochai, Weinstein, Orly, Cohen, Arnon Dov, Cicurel, Assi Albert, Feingold, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928567/ https://www.ncbi.nlm.nih.gov/pubmed/33604657 http://dx.doi.org/10.1093/schbul/sbab012 |
Ejemplares similares
-
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study
por: Tzur Bitan, Dana, et al.
Publicado: (2021) -
Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel
por: Tzur Bitan1,2, Dana, et al.
Publicado: (2022) -
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study
por: Kridin, Khalaf, et al.
Publicado: (2022) -
COVID-19 vaccination among individuals with autism spectrum disorder: A population-based study
por: Weinstein, Orly, et al.
Publicado: (2021) -
Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment—a population-based cohort study
por: Kridin, Khalaf, et al.
Publicado: (2021)